Article citationsMore>>

Stephenson, A., Eggener, S.E., Bass, E.B., Chelnick, D.M., Daneshmand, S., Feldman, D., Gilligan, T., Karam, J.A., Leibovich, B., Liauw, S.L., Masterson, T.A., Meeks, J.J., Pierorazio, P.M., Sharma, R. and Sheinfeld, J. (2019) Diagnosis and Treatment of Early Stage Testicular Cancer: American Urological Association Guideline. The Journal of Urology, 202, 272-281.
https://doi.org/10.1097/JU.0000000000000318

has been cited by the following article:

• TITLE: Management of Testicular Cancers in Brazzaville

  AUTHORS: Roland Bertile Banga-Mouss, Yanick Dimi Nyanga, Brice Nkoua Epala, Armel Melvin Atipo Ondongo, Steve Aristid Ondziel-Opara, Eliane Ndounga, Alexis Bolenga, Louis Constant Mbele Mantsouaka, Judith Nsonde Malanda, Aanani Séverin Wencesl Odzébé, Prosper Alain Bouya

  KEYWORDS: Testicular Cancer, Germ Cell Tumor, Cisplatin, Testicular Lymphoma, Testicular Adenocarcinoma

  JOURNAL NAME: Open Journal of Urology, Vol.14 No.5, May 21, 2024

  ABSTRACT: Introduction: Testicular cancer accounts for 5% of urological tumors, predominantly affecting young men. The aim of our study was to report the diagnostic and evolutionary aspects of testicular cancer cases treated in our center. Patients and Methods: A retrospective study conducted over a 15-year period involving 12 patients treated for testicular cancer at the University Hospital of Brazzaville. Results: The median age was 31 years (range 11 to 49 years), with a median consultation delay of 10.6 months (range 3 to 27 months). Scrotal mass was the most common reason for consultation. Cancer was bilateral in two patients. Two patients were admitted with metastatic disease. Histopathological examination favored germ cell tumors in 7 cases, two cases of non-Hodgkin’s malignant lymphoma, and one case of epididymo-testicular adenocarcinoma. Adjuvant chemotherapy resulted in complete remission in patients with germ cell tumors. However, neoadjuvant chemotherapy was not effective in patients admitted with advanced-stage disease. Conclusion: Testicular cancer is a rare condition that is curable in the majority of cases, but its management is often complicated in our setting due to delayed diagnosis caused by taboos surrounding genital organ pathologies.